GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Jaguar Health Inc.
Jaguar Health is a pharmaceutical company specializing in herbal medicines for gastrointestinal disorders. Its stock price reflects both the commercial success of its products and the research behind their use.
Share prices of companies in the market segment - Pharma git
Jaguar Health is a pharmaceutical company focused on developing herbal medicines for the treatment of gastrointestinal disorders in humans and animals. We have classified it in the Pharma: Gastrointestinal category. The chart below shows how the market values companies working in natural medicines.
Broad Market Index - GURU.Markets
Jaguar Health is a pharmaceutical company focused on developing herbal medicines for the treatment of gastrointestinal disorders in humans and animals. It is a component of the GURU.Markets index. The chart below represents the market. See how this company's stock compares to the pharmaceutical sector.
Change in the price of a company, segment, and market as a whole per day
JAGX - Daily change in the company's share price Jaguar Health Inc.
Jaguar Health, Inc.'s daily stock price fluctuations reflect the high volatility inherent in biotech companies. This metric measures the company's sensitivity to sales of its herbal drug and news about clinical trials.
Daily change in the price of a set of shares in a market segment - Pharma git
Jaguar Health is a pharmaceutical company focused on developing herbal medicines for the treatment of gastrointestinal disorders in humans and animals. The chart below shows the volatility in this specialized segment, helping to understand the unique dynamics of JAGX stock.
Daily change in the price of a broad market stock, index - GURU.Markets
Jaguar Health is a pharmaceutical company specializing in the treatment of gastrointestinal diseases in humans and animals. Its diversified approach makes its shares sensitive to trends in both human and veterinary healthcare.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Jaguar Health Inc.
For Jaguar Health, Inc., year-over-year performance is the story of its herbal gastrointestinal products. Its 12-month market cap is entirely dependent on success in expanding the indications for its flagship drug, crofelemer. Approval for the treatment of chemotherapy-induced diarrhea could be a fundamental breakthrough for the company.
Annual dynamics of market capitalization of the market segment - Pharma git
Jaguar Health, Inc. is a commercial pharmaceutical company focused on developing herbal medicines for the treatment of gastrointestinal diseases. This chart illustrates how its unique niche strategy and efforts to expand the reach of its medications influence its volatile performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Jaguar Health, a company specializing in herbal medicines, demonstrates with its growth whether there's room for such a niche in big pharma. Its performance relative to the market depends on sales of its core product and its success in expanding its use, making it a unique story at the intersection of nature and science.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Jaguar Health Inc.
Jaguar Health is a commercial pharmaceutical company. Its monthly performance is directly dependent on the commercial success of its drug, Mytesi. Quarterly reports on prescription growth and progress in research into new indications are key indicators.
Monthly dynamics of market capitalization of the market segment - Pharma git
The market for herbal remedies for specific conditions, such as gastrointestinal disorders, is a niche market. The dynamics of this segment, shown in the graph, reflect its specificity. Companies like Jaguar Health offer unique treatments in this area.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Jaguar Health, a biopharmaceutical company specializing in herbal medicines, has a unique niche. Its stock moves on approval and sales news rather than general market trends, creating an independent profile.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Jaguar Health Inc.
Jaguar Health, a pharmaceutical company developing plant-based therapies for the treatment of gastrointestinal diseases in humans and animals, has a unique niche. Its weekly stock performance reflects both clinical trial data and the commercial success of its already approved products.
Weekly dynamics of market capitalization of the market segment - Pharma git
Jaguar Health develops plant-based therapies for the treatment of gastrointestinal disorders in humans and animals. This is a niche approach in pharmaceuticals. The chart shows how investors value its products and how the company's performance compares to traditional biotech companies.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Jaguar Health develops plant-based drugs, a niche approach in pharmaceuticals. The chart below shows how investors value its products and how the company's performance compares to traditional biotech and the broader market.
Market capitalization of the company, segment and market as a whole
JAGX - Market capitalization of the company Jaguar Health Inc.
Jaguar Health's market capitalization reflects investors' valuation of its unique herbal medicine. The chart shows the market value of its drug Mytesi (crofelemer), which treats diarrhea in HIV patients. Its low price reflects its very niche market and its ongoing efforts to expand its use to other conditions.
JAGX - Share of the company's market capitalization Jaguar Health Inc. within the market segment - Pharma git
Jaguar Health is a pharmaceutical company focused on developing plant-based therapies for gastrointestinal disorders. Its market share is small, but it is a leader in its unique niche. Its market capitalization is based on its drug Mytesi, approved for the treatment of diarrhea in patients with HIV/AIDS.
Market capitalization of the market segment - Pharma git
This graph shows the total value of the entire pharmaceutical sector focused on gastrointestinal diseases. For Jaguar Health, with its unique herbal medicines, this line represents a map of unmet needs. Its dynamics demonstrate the size of the market for effective treatments for common digestive disorders.
Market capitalization of all companies included in a broad market index - GURU.Markets
Jaguar Health develops herbal medicines for the treatment of gastrointestinal disorders. Its market capitalization is the valuation of "natural" pharmaceuticals. This represents the market share of the company, which searches for cures in tropical forests.
Book value capitalization of the company, segment and market as a whole
JAGX - Book value capitalization of the company Jaguar Health Inc.
Jaguar Health is a pharmaceutical company specializing in herbal medicines for gastrointestinal disorders. Its book value is its financial resources and the inventory of its approved drug, Mytesi. This is its capital for marketing and research. How has this changed? The chart below shows.
JAGX - Share of the company's book capitalization Jaguar Health Inc. within the market segment - Pharma git
Jaguar Health, Inc. is a pharmaceutical company developing plant-based medicines. Its business relies on R&D infrastructure for research and manufacturing capabilities for its drug, Mytesi. The chart shows its share of physical assets required for phytopharmaceutical production.
Market segment balance sheet capitalization - Pharma git
Jaguar Health is a pharmaceutical company. Pharmaceuticals, as the graph shows, are both knowledge- and capital-intensive. As a commercial company, Jaguar invests not only in R&D but also in the infrastructure to market its products.
Book value of all companies included in the broad market index - GURU.Markets
Jaguar Health's assets are not farms, but a unique business model for developing medicines from tropical forest plants, specifically a treatment for diarrhea in humans and animals. Its book value reflects its scientific potential and commercial infrastructure.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Jaguar Health Inc.
Jaguar Health is a pharmaceutical company focused on developing herbal medicines. Its market capitalization is based on its unique approach and its flagship product for the treatment of diarrhea.
Market to book capitalization ratio in a market segment - Pharma git
Jaguar Health is a pharmaceutical company developing plant-based therapies for gastrointestinal disorders. Its valuation on this chart reflects both its unique approach and the risks associated with commercializing its niche products.
Market to book capitalization ratio for the market as a whole
Jaguar Health is a pharmaceutical company focused on herbal medicines for gastrointestinal disorders. This niche approach in pharmaceuticals helps understand how the market values companies using alternative sources to create medications.
Debts of the company, segment and market as a whole
JAGX - Company debts Jaguar Health Inc.
Jaguar Health, a pharmaceutical company focused on herbal therapeutics for gastrointestinal disorders, uses capital to fund sales, marketing, and clinical research to expand indications. This chart illustrates the financial challenges of commercializing niche drugs.
Market segment debts - Pharma git
Jaguar Health is a pharmaceutical company specializing in the development of plant-based therapies for the treatment of gastrointestinal disorders in both humans and animals. This chart illustrates how the company, operating in a unique niche, funds its clinical trials and commercialization, a challenging task for non-traditional therapies.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Jaguar Health Inc.
Jaguar Health is a pharmaceutical company specializing in the development of herbal medicines for the treatment of gastrointestinal disorders in humans and animals. Clinical trials, even for herbal medicines, require significant investment. This chart shows how the company uses debt to fund its unique R&D programs.
Market segment debt to market segment book capitalization - Pharma git
Jaguar Health is a pharmaceutical company focused on developing plant-based therapies for the treatment of gastrointestinal disorders in humans and animals. This chart shows how the company finances its unique R&D activities. It compares its debt to the market capitalization of the entire pharmaceutical sector, reflecting its niche strategy.
Debt to book value of all companies in the market
Jaguar Health is a pharmaceutical company focused on developing herbal medications for gastrointestinal disorders. This is a niche area that requires investment in research and clinical trials. How heavily does the company rely on debt? This chart of total market debt helps evaluate its financial strategy.
P/E of the company, segment and market as a whole
P/E - Jaguar Health Inc.
Jaguar Health is a commercial pharmaceutical company focused on developing herbal medicines for the treatment of gastrointestinal disorders. This chart shows how investors value its core product and development pipeline.
P/E of the market segment - Pharma git
Jaguar Health is a commercial pharmaceutical company focused on developing herbal medicines for the treatment of gastrointestinal disorders in humans and animals. This chart illustrates the average valuation in the pharmaceutical sector, where investors evaluate the potential of herbal medicines and niche markets.
P/E of the market as a whole
Jaguar Health, Inc. is a commercial pharmaceutical company focused on developing herbal medicines for the treatment of gastrointestinal disorders in humans and animals. This chart reflects the overall sentiment in the pharmaceutical sector. It helps us understand what influences JAGX's valuation more: overall market trends or the commercial success of its niche products.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Jaguar Health Inc.
Jaguar Health is a pharmaceutical company focused on developing herbal medicines for the treatment of gastrointestinal disorders in humans and animals. This chart shows how investors assess the commercial potential of its unique herbal medicines and their success in bringing them to market for various indications.
%20P%2FE%20Jaguar%20Health%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Jaguar-Health-Inc.&v=1772641478801 "Chart of the company's future (projected) P/E Jaguar Health Inc.")
Future (projected) P/E of the market segment - Pharma git
Jaguar Health is a pharmaceutical company developing plant-based therapies for the treatment of gastrointestinal disorders in both humans and animals. The chart compares Jaguar's future profitability expectations with the sector, helping to understand how the market views its unique approach based on natural ingredients.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20git&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-git&v=1772641478815 "Future (projected) P/E graph of the market segment - Pharma git")
Future (projected) P/E of the market as a whole
Jaguar Health is a pharmaceutical company focused on developing plant-based therapies for the treatment of gastrointestinal disorders in humans and animals. This market sentiment chart helps assess investor sentiment toward companies using natural sources to create medications, a niche approach in the pharmaceutical industry.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772641478831 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Jaguar Health Inc.
Jaguar Health, Inc. is a pharmaceutical company that develops and commercializes plant-based therapies for the treatment of gastrointestinal disorders in both humans and animals. Profits are driven by sales of its products. This chart shows the financial performance of the company, which uses a unique approach to drug discovery in nature.
Profit of companies in the market segment - Pharma git
Jaguar Health, Inc. is a pharmaceutical company focused on developing herbal medicines for the treatment of gastrointestinal disorders in humans and animals. This chart shows the overall profitability of the gastroenterology sector, where the use of natural sources to create medications can offer unique and safe therapeutic solutions.
Overall market profit
Jaguar Health, Inc. develops and commercializes herbal medicines for the treatment of gastrointestinal disorders. Demand for its products is driven by medical needs. This business falls within the protective healthcare sector and is not subject to general economic cycles, as can be seen in this chart.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Jaguar Health Inc.
Jaguar Health is a pharmaceutical company focused on developing herbal medicines for the treatment of gastrointestinal diseases in humans and animals. Future profits depend on sales of its core product. This chart shows analyst expectations for its niche strategy.
%20profit%20of%20the%20company%20Jaguar%20Health%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Jaguar-Health-Inc.&v=1772641478867 "Graph of future (projected) profit of the company Jaguar Health Inc.")
Future (predicted) profit of companies in the market segment - Pharma git
Jaguar Health is a pharmaceutical company specializing in the development of herbal medicines for the treatment of gastrointestinal disorders in humans and animals. Its key product, Mytesi, is used to treat diarrhea. This chart shows profitability expectations for the pharmaceutical sector, providing context for assessing Jaguar's niche strategy.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20git&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-git&v=1772641478883 "Graph of future (predicted) profits of companies in a market segment - Pharma git")
Future (predicted) profit of the market as a whole
Jaguar Health, Inc. is a pharmaceutical company developing herbal medications for the treatment of gastrointestinal disorders. Its commercial success depends on sales and market acceptance of its products. This economic outlook impacts the overall solvency of the healthcare system and the willingness of insurers to cover new medications.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772641478884 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Jaguar Health Inc.
Jaguar Health is a pharmaceutical company focused on developing plant-based treatments for gastrointestinal disorders. Revenue is driven by sales of its core product. This chart shows how investors view its unique approach to drug discovery in nature.
P/S market segment - Pharma git
Jaguar Health is a commercial pharmaceutical company focused on developing herbal medicines for the treatment of gastrointestinal disorders in humans and animals. Their first product has been approved for the treatment of diarrhea in dogs. This chart reflects the average revenue estimate for the sector, which helps assess how the market views this pharmaceutical niche.
P/S of the market as a whole
Jaguar Health is a pharmaceutical company specializing in the development of plant-based therapies for the treatment of gastrointestinal disorders in humans and animals. This graph, showing average revenue estimates, helps assess market sentiment for a company with a unique approach to drug discovery in nature.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Jaguar Health Inc.
Jaguar Health is a pharmaceutical company specializing in the development of herbal medicines for the treatment of gastrointestinal disorders in humans and animals. Estimates based on future revenue are important to the company. They reflect investor expectations for sales growth of its core product and the success of its clinical programs in new indications, such as the prevention of diarrhea in cancer patients.
%20P%2FS%20Jaguar%20Health%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Jaguar-Health-Inc.&v=1772641478991 "The graph of the company's future (projected) P/S Jaguar Health Inc.")
Future (projected) P/S of the market segment - Pharma git
Jaguar Health is a pharmaceutical company developing herbal medicines for the treatment of gastrointestinal disorders, particularly diarrhea. This chart compares the company's estimated future sales with industry expectations. It shows how investors view the commercial success of its existing products and the potential for expansion.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20git&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-git&v=1772641479007 "Future (projected) P/S market segment graph - Pharma git")
Future (projected) P/S of the market as a whole
Jaguar Health is a pharmaceutical company specializing in the development of herbal medicines for the treatment of gastrointestinal diseases in humans and animals. The company's success depends on sales of its flagship product, Mytesi. This graph of investor expectations reflects their interest in niche pharmaceutical markets and natural products.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772641479011 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Jaguar Health Inc.
The graph shows Jaguar Health's revenue from sales of its flagship product, Mytesi (crofelemer), a herbal treatment for diarrhea in HIV patients. Revenue growth is driven by increased prescription volume and research into new indications for the drug.
Sales of companies in the market segment - Pharma git
Jaguar Health is a pharmaceutical company focused on developing herbal medicines for the treatment of gastrointestinal disorders. Its revenue is generated by sales of Mytesi. Its sales breakdown reflects its use in both humans and animals, demonstrating its unique niche.
Overall market sales
Jaguar Health, Inc. is a pharmaceutical company developing herbal medicines for the treatment of gastrointestinal disorders in humans and animals. The company operates in the phytopharmaceuticals niche. This general economics does not affect the demand for its products, which is driven by medical needs and acceptance by physicians and veterinarians.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Jaguar Health Inc.
Jaguar Health is a commercial pharmaceutical company focused on developing herbal medicines for the treatment of gastrointestinal disorders in humans and animals. Revenue growth is driven by sales of its flagship drug, Mytesi. This chart shows analysts' forecasts for demand for its products and the expansion of their indications.
%20sales%20of%20the%20company%20Jaguar%20Health%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Jaguar-Health-Inc.&v=1772641479040 "Schedule of future (projected) sales of the company Jaguar Health Inc.")
Future (projected) sales of companies in the market segment - Pharma git
Jaguar Health, Inc. develops herbal medications for the treatment of gastrointestinal disorders in humans and animals. This chart shows the forecast for the pharmaceutical market. Is demand for specialized supportive care medications growing? This reflects general trends in this niche.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20git&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-git&v=1772641479057 "Schedule of future (projected) sales of companies in the market segment - Pharma git")
Future (projected) sales of the market as a whole
Jaguar Health is a pharmaceutical company specializing in the development of herbal medications for the treatment of gastrointestinal disorders. Demand for its products is driven by medical needs and physician prescriptions. The overall economic situation, reflected in this chart, has minimal impact on treatment decisions for diarrhea and other similar conditions.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772641479070 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Jaguar Health Inc.
Jaguar Health is a pharmaceutical company focused on developing herbal medicines for the treatment of gastrointestinal disorders in humans and animals. This chart shows its path to profitability. Profitability depends on sales of its approved drug and the expansion of its use in the treatment of side effects of cancer therapy.
Market segment marginality - Pharma git
Jaguar Health, Inc. is a pharmaceutical company specializing in the development of herbal medicines for the treatment of gastrointestinal disorders in humans and animals. This metric reflects its financial position, where profitability depends on successful sales of its approved products and the expansion of their use.
Market marginality as a whole
Jaguar Health is a pharmaceutical company focused on developing plant-based therapies for the treatment of gastrointestinal disorders in humans and animals. This gross margin chart reflects the state of both human and veterinary healthcare, as well as consumer willingness to pay for niche medications.
Employees in the company, segment and market as a whole
Number of employees in the company Jaguar Health Inc.
Jaguar Health is a pharmaceutical company focused on developing plant-based therapies for the treatment of gastrointestinal disorders in humans and animals. Its small staff manages commercialization and research. This graphic shows the compact team working to expand the indications for its lead product, Mytesi.
Share of the company's employees Jaguar Health Inc. within the market segment - Pharma git
Jaguar Health is a pharmaceutical company focused on developing plant-based treatments for gastrointestinal disorders. Its operations require a team of botanists, pharmacologists, and clinicians. This chart shows the company's market share, reflecting its unique niche and the scale of its research and commercial activities.
Number of employees in the market segment - Pharma git
Jaguar Health is a pharmaceutical company specializing in the development of herbal medicines for gastrointestinal disorders. Its key product is used to treat diarrhea in HIV/AIDS patients. The chart illustrates employment in this area. Jaguar's approach is based on the principles of sustainable harvesting of medicinal plants.
Number of employees in the market as a whole
Jaguar Health is a pharmaceutical company focused on developing herbal medicines for gastrointestinal disorders. Its growth depends on success in clinical trials and commercialization. This chart illustrates general trends, and Jaguar is an example of a niche company operating at the intersection of traditional medicine and pharmaceuticals.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Jaguar Health Inc. (JAGX)
Jaguar Health is a pharmaceutical company focused on herbal gastrointestinal therapeutics, with Mytesi as their flagship product. This chart shows how the market views their niche strategy. It reflects the market value per employee, which is a measure of the value of their commercial product and R&D pipeline.
%20of%20the%20company%20Jaguar%20Health%20Inc.%20(JAGX)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Jaguar-Health-Inc.-JAGX&v=1772641479203 "Chart of market capitalization per employee (in thousands of dollars) of the company Jaguar Health Inc. (JAGX)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma git
Jaguar Health (JAGX) is a pharmaceutical company developing herbal treatments for gastrointestinal disorders in humans and animals. This chart shows how the market is valuing their unique approach. Their high per-employee value may be related to their drug Mytesi, the only approved herbal treatment for diarrhea in HIV-infected individuals.
%20by%20market%20segment%20-%20Pharma%20git&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-git&v=1772641479216 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma git")
Market capitalization per employee (in thousands of dollars) for the overall market
Jaguar Health is a pharmaceutical company developing plant-based treatments for gastrointestinal disorders. Its value is determined by the uniqueness of its approach and the commercial success of its products. This metric reflects how the market perceives the potential of its niche products for humans and animals.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772641479217 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Jaguar Health Inc. (JAGX)
Jaguar Health is a pharmaceutical company focused on developing botanical-based therapies for the treatment of gastrointestinal diseases in humans and animals. This chart shows the company's success in commercializing its niche drugs. Earnings per employee is the sales revenue that covers R&D and marketing.
%20Chart%20Jaguar%20Health%20Inc.%20(JAGX)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Jaguar-Health-Inc.-JAGX&v=1772641479221 "Company Profit Per Employee (in thousands of dollars) Chart Jaguar Health Inc. (JAGX)")
Profit per employee (in thousands of dollars) in the market segment - Pharma git
Jaguar Health, Inc. is a pharmaceutical company specializing in the development of herbal medicines for the treatment of gastrointestinal disorders. The efficiency per employee reflects their unique niche. The graph shows how successfully the company is commercializing its unconventional, yet in-demand, medications.
%20in%20the%20market%20segment%20-%20Pharma%20git&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-git&v=1772641479242 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma git")
Profit per employee (in thousands of dollars) for the market as a whole
Jaguar Health is a pharmaceutical company focused on the gastrointestinal tract. Their unique product line is herbal medicines (Mytesi) for the treatment of diarrhea in humans (and animals). This is a niche pharmaceutical. This chart helps us understand how this FDA-approved, herbal-based business compares in terms of employee efficiency.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772641479244 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Jaguar Health Inc. (JAGX)
Jaguar Health is a pharmaceutical company focused on herbal medicines for gastrointestinal disorders. This chart measures the commercial success of their unique products. The growth in revenue per employee demonstrates the expanding use of their medicines for both humans and animals.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Jaguar-Health-Inc.-JAGX&v=1772641479247 "Sales chart per company employee Jaguar Health Inc. (JAGX)")
Sales per employee in the market segment - Pharma git
Jaguar Health (JAGX) is a pharmaceutical company focused on treating gastrointestinal disorders. Their key product (Mytesi/Canalevia) is a herbal treatment for diarrhea (in humans with HIV and in dogs). This chart shows the average sales volume for the sector. For JAGX, this is an indicator of how productive their team is in selling this niche drug.
Sales per employee for the market as a whole
Jaguar Health (JAGX) is a commercial-stage pharmaceutical company. Their flagship product, Mytesi, is a herbal treatment for diarrhea in HIV patients. This indicator demonstrates how effective their small team is in selling this niche drug.
Short shares by company, segment and market as a whole
Shares shorted by company Jaguar Health Inc. (JAGX)
Jaguar Health (JAGX) is a pharmaceutical company whose lead product (Mytesi) is approved for the treatment of diarrhea in HIV patients and is attempting to expand it into other indications. This chart shows the number of short positions. The short positions reflect concerns about the broad market potential of this niche drug.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Jaguar-Health-Inc.-JAGX&v=1772641479261 "Short Shares Chart for the Company Jaguar Health Inc. (JAGX)")
Shares shorted by market segment - Pharma git
Jaguar Health (JAGX) is a pharmaceutical company specializing in the development of herbal remedies (from the Croton bark plant) for the treatment of gastrointestinal disorders such as diarrhea. This chart shows the total short position in the biotech sector, reflecting investor concerns about the commercialization of niche drugs.
Shares shorted by the overall market
Jaguar Health is a pharmaceutical company focused on gastrointestinal health products. Despite having an approved product, the company chronically struggles with profitability and is constantly in need of capital. This chart measures the overall fear. As pessimism rises, investors ruthlessly sell off shares of "perpetual" R&D projects like JAGX, fearing share dilution or bankruptcy.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Jaguar Health Inc. (JAGX)
This oscillator shows the chronic volatility of Jaguar Health. The entire company is built around a single drug (Mytesi) for the treatment of a specific diarrhea. Investors are overheating the stock (above 70) on any rumors of expanded indications, especially for cancer patients. However, a long-standing history of reverse splits and a lack of cash keeps the indicator oversold.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Jaguar-Health-Inc.-JAGX&v=1772641479292 "RSI 14 indicator chart for the company's stock Jaguar Health Inc. (JAGX)")
RSI 14 Market Segment - Pharma git
Jaguar Health is a pharmaceutical company focused on treating gastrointestinal disorders. Their key drug, Crofelemer (Mytesi), is derived from a plant-based compound and is used to treat diarrhea in HIV patients. This chart reflects the overall sentiment in the biotech sector, helping to gauge the overall market sentiment toward this speculative industry.
RSI 14 for the overall market
Jaguar Health (JAGX) develops herbal therapies for gastrointestinal diseases. As a development-stage biotech company, it is extremely sensitive to investor sentiment. This chart shows the overall market "temperature." When the market is "overheated," it's easier to find capital for clinical trials, but in times of "panic," funding becomes scarce.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast JAGX (Jaguar Health Inc.)
Jaguar Health is a pharmaceutical company focused on herbal medicines. Its key product, Mytesi (Crofelemer), treats diarrhea in HIV patients. This chart shows the speculative average 12-month price target from analysts, based on their forecasts for prescription growth for this drug.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-JAGX-Jaguar-Health-Inc.&v=1772641479315 "A chart showing analyst consensus forecasts for the expected stock price. JAGX (Jaguar Health Inc.)")
The difference between the consensus estimate and the actual stock price JAGX (Jaguar Health Inc.)
Jaguar Health is an "ethnobotany" company. The company develops plant-based medications (Mytesi from Croton bark) for the treatment of gastrointestinal issues, particularly diarrhea in HIV patients. This chart illustrates the analyst community's opinion on the company's future. It measures the distance between the stock price and the target, reflecting their belief in this plant-based R&D portfolio.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-JAGX-Jaguar-Health-Inc.&v=1772641479331 "A chart showing the difference between the consensus forecast and the actual stock price. JAGX (Jaguar Health Inc.)")
Analyst consensus forecast for stock prices by market segment - Pharma git
Jaguar Health is a single-molecule pharmaceutical company. Its flagship drug (Mytesi, derived from tree bark) is approved for the treatment of diarrhea in HIV patients and is being studied for use in cancer patients. This chart displays analysts' overall expectations across the pharmaceutical (gastrointestinal) sector. It shows whether experts believe this niche drug will see widespread use.
Analysts' consensus forecast for the overall market share price
Jaguar Health is a pharmaceutical company focused on treating gastrointestinal disorders. Their key drug (Mytesi) is designed to alleviate diarrhea in patients undergoing specific therapy. This chart shows overall market sentiment. For JAGX, which operates in the "defensive" sector (healthcare), overall optimism (a rising chart) is important for funding.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Jaguar Health Inc.
Jaguar Health is a jungle pharma. Their signature product is Mytesi (Crofelemer), a herbal drug (derived from tree resin) approved for the treatment of diarrhea in HIV patients. They are trying to expand it to IBS and cancer. This chart is a summary indicator of their single-brand product. It reflects their (meager) sales and their (very risky) bets on new R&D.
AKIMA Market Segment Index - Pharma git
Jaguar Health is a pharmaceutical company focused on gastrointestinal health. Their flagship drug, Mytesi, is derived from plant-based ingredients and treats diarrhea in HIV patients. This chart compares their composite index to the sector, showing how this highly specialized plant-based pharmaceutical company competes with others.
The AKIM Index for the overall market
Jaguar Health is a pharmaceutical company that markets Mytesi, a herbal treatment for diarrhea in HIV patients and dogs. This chart, which reflects the market average, provides a macro backdrop. It helps assess how JAGX, a niche commercial player, compares to overall economic trends.
